|
|
|
Royal Pharmaceutical Society , London
20-06-2012
By the end of the course you will have received an intensive course of study on the relevance of dissolution testing to the assessment of dosage forms (in particular oral dosage forms), dissolution method development, validation and - You will understand:
- the relevance of dissolution testing to industry & regulators
- dissolution equipment
- dissolution media
- compendial requirements & testing
- method development
- method validation
- Learn about the current state of knowledge of the subject, both in terms of theoretical basis and practical experience.
- Acquire skills and knowledge you will be able to apply to day-to-day problems in dissolution testing, linked to a sound theoretical knowledge of the principles involved.
- Formed lasting contacts with colleagues in the field, as well as the expert course tutors.
|
|
|
|
|
|
Organized by:
|
|
Royal Pharmaceutical Society |
|
Invited Speakers:
|
|
James Butler - Science Manager, GSK, Ware | Paul Dickinson - AstraZeneca, Macclesfield | Lee Dowden - MSD, Hoddesdon | Nikoletta Fotaki - University of Bath | Dave Holt - AstraZeneca, Macclesfield | Evangelos Kotzagiogis - Science Administrator, EMA, London | James Mann - MSD, Hoddesdon | Terry Way - USP Consultant, Cambridge |
|
|
|
|
|
|
Deadline for Abstracts:
|
|
20-06-2012
|
|
|
|
|
|
Registration:
|
|
To register for this event please go to: https://www.rpharms.com/events-and-courses/dissolution-testing.asp
|
|
E-mail:
|
|
events@rpharms.com
|
|
|
|
|
|
|
|